annual accounts payable:
$11.64M-$9.25M(-44.27%)Summary
- As of today (May 25, 2025), BCRX annual accounts payable is $11.64 million, with the most recent change of -$9.25 million (-44.27%) on December 31, 2024.
- During the last 3 years, BCRX annual accounts payable has fallen by -$16.16 million (-58.13%).
- BCRX annual accounts payable is now -58.13% below its all-time high of $27.81 million, reached on December 31, 2021.
Performance
BCRX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$10.05M-$1.59M(-13.70%)Summary
- As of today (May 25, 2025), BCRX quarterly accounts payable is $10.05 million, with the most recent change of -$1.59 million (-13.70%) on March 31, 2025.
- Over the past year, BCRX quarterly accounts payable has dropped by -$1.86 million (-15.63%).
- BCRX quarterly accounts payable is now -63.86% below its all-time high of $27.81 million, reached on December 31, 2021.
Performance
BCRX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BCRX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.3% | -15.6% |
| 3 y3 years | -58.1% | -27.6% |
| 5 y5 years | -16.8% | -0.1% |
BCRX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.1% | at low | -51.9% | +60.7% |
| 5 y | 5-year | -58.1% | at low | -63.9% | +60.7% |
| alltime | all time | -58.1% | +5722.0% | -63.9% | +9949.0% |
BCRX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $10.05M(-13.7%) |
| Dec 2024 | $11.64M(-44.3%) | $11.64M(-13.6%) |
| Sep 2024 | - | $13.48M(+73.2%) |
| Jun 2024 | - | $7.79M(-34.6%) |
| Mar 2024 | - | $11.91M(-43.0%) |
| Dec 2023 | $20.89M(+45.5%) | $20.89M(+97.7%) |
| Sep 2023 | - | $10.57M(-23.9%) |
| Jun 2023 | - | $13.89M(+122.1%) |
| Mar 2023 | - | $6.25M(-56.4%) |
| Dec 2022 | $14.36M(-48.4%) | $14.36M(+66.5%) |
| Sep 2022 | - | $8.62M(-28.3%) |
| Jun 2022 | - | $12.02M(-13.4%) |
| Mar 2022 | - | $13.88M(-50.1%) |
| Dec 2021 | $27.81M(+48.6%) | $27.81M(+41.2%) |
| Sep 2021 | - | $19.69M(+95.2%) |
| Jun 2021 | - | $10.09M(-25.4%) |
| Mar 2021 | - | $13.53M(-27.7%) |
| Dec 2020 | $18.71M(+33.8%) | $18.71M(+61.1%) |
| Sep 2020 | - | $11.62M(+24.2%) |
| Jun 2020 | - | $9.35M(-7.0%) |
| Mar 2020 | - | $10.06M(-28.1%) |
| Dec 2019 | $13.99M(+80.0%) | $13.99M(+38.7%) |
| Sep 2019 | - | $10.08M(+21.5%) |
| Jun 2019 | - | $8.30M(+19.7%) |
| Mar 2019 | - | $6.93M(-10.7%) |
| Dec 2018 | $7.77M(+22.6%) | $7.77M(-1.8%) |
| Sep 2018 | - | $7.91M(+91.9%) |
| Jun 2018 | - | $4.12M(+14.9%) |
| Mar 2018 | - | $3.59M(-43.4%) |
| Dec 2017 | $6.34M(+48.4%) | $6.34M(+37.7%) |
| Sep 2017 | - | $4.60M(+149.6%) |
| Jun 2017 | - | $1.84M(-66.1%) |
| Mar 2017 | - | $5.43M(+27.3%) |
| Dec 2016 | $4.27M(-54.1%) | $4.27M(+54.7%) |
| Sep 2016 | - | $2.76M(-45.4%) |
| Jun 2016 | - | $5.05M(-34.3%) |
| Mar 2016 | - | $7.69M(-17.4%) |
| Dec 2015 | $9.31M(+226.7%) | $9.31M(+146.1%) |
| Sep 2015 | - | $3.78M(-1.0%) |
| Jun 2015 | - | $3.82M(-28.0%) |
| Mar 2015 | - | $5.31M(+86.3%) |
| Dec 2014 | $2.85M(-31.7%) | $2.85M(+25.7%) |
| Sep 2014 | - | $2.27M(-4.0%) |
| Jun 2014 | - | $2.36M(+74.6%) |
| Mar 2014 | - | $1.35M(-67.6%) |
| Dec 2013 | $4.17M(+5.0%) | $4.17M(+236.3%) |
| Sep 2013 | - | $1.24M(+25.5%) |
| Jun 2013 | - | $989.00K(-7.8%) |
| Mar 2013 | - | $1.07M(-73.0%) |
| Dec 2012 | $3.97M(+59.2%) | $3.97M(+73.3%) |
| Sep 2012 | - | $2.29M(-31.1%) |
| Jun 2012 | - | $3.33M(+61.4%) |
| Mar 2012 | - | $2.06M(-17.4%) |
| Dec 2011 | $2.50M(-69.6%) | $2.50M(-30.3%) |
| Sep 2011 | - | $3.58M(-28.5%) |
| Jun 2011 | - | $5.01M(-19.9%) |
| Mar 2011 | - | $6.25M(-23.7%) |
| Dec 2010 | $8.20M(-54.6%) | $8.20M(+151.5%) |
| Sep 2010 | - | $3.26M(+126.8%) |
| Jun 2010 | - | $1.44M(-77.4%) |
| Mar 2010 | - | $6.35M(-64.8%) |
| Dec 2009 | $18.07M | $18.07M(+464.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $3.20M(+14.6%) |
| Jun 2009 | - | $2.79M(-33.3%) |
| Mar 2009 | - | $4.18M(-20.5%) |
| Dec 2008 | $5.27M(-73.4%) | $5.27M(+62.6%) |
| Sep 2008 | - | $3.24M(-65.2%) |
| Jun 2008 | - | $9.32M(-36.9%) |
| Mar 2008 | - | $14.76M(-25.3%) |
| Dec 2007 | $19.77M(+235.8%) | $19.77M(+20.7%) |
| Sep 2007 | - | $16.38M(+54.9%) |
| Jun 2007 | - | $10.58M(+28.9%) |
| Mar 2007 | - | $8.21M(+39.4%) |
| Dec 2006 | $5.89M(-33.2%) | $5.89M(-26.2%) |
| Sep 2006 | - | $7.97M(+53.2%) |
| Jun 2006 | - | $5.21M(-24.2%) |
| Mar 2006 | - | $6.87M(-22.1%) |
| Dec 2005 | $8.81M(+347.3%) | $8.81M(+295.0%) |
| Sep 2005 | - | $2.23M(+84.7%) |
| Jun 2005 | - | $1.21M(-27.8%) |
| Mar 2005 | - | $1.67M(-15.1%) |
| Dec 2004 | $1.97M(+207.7%) | $1.97M(-2.6%) |
| Sep 2004 | - | $2.02M(+138.4%) |
| Jun 2004 | - | $849.00K(-19.4%) |
| Mar 2004 | - | $1.05M(+64.6%) |
| Dec 2003 | $640.30K(+150.1%) | $640.30K(+39.5%) |
| Sep 2003 | - | $459.00K(-25.6%) |
| Jun 2003 | - | $617.00K(+127.7%) |
| Mar 2003 | - | $271.00K(+5.9%) |
| Dec 2002 | $256.00K(-58.5%) | $256.00K(-44.3%) |
| Sep 2002 | - | $460.00K(-40.6%) |
| Jun 2002 | - | $775.00K(+121.4%) |
| Mar 2002 | - | $350.00K(-43.3%) |
| Dec 2001 | $617.60K(-23.2%) | $617.60K(+68.3%) |
| Sep 2001 | - | $367.00K(+25.7%) |
| Jun 2001 | - | $292.00K(+21.7%) |
| Mar 2001 | - | $240.00K(-70.2%) |
| Dec 2000 | $804.10K(+168.0%) | $804.10K(+216.6%) |
| Sep 2000 | - | $254.00K(-72.2%) |
| Jun 2000 | - | $915.00K(+125.8%) |
| Mar 2000 | - | $405.20K(+35.1%) |
| Dec 1999 | $300.00K(+50.0%) | $300.00K(+200.0%) |
| Sep 1999 | - | $100.00K(-66.7%) |
| Jun 1999 | - | $300.00K(+50.0%) |
| Mar 1999 | - | $200.00K(0.0%) |
| Dec 1998 | $200.00K(0.0%) | $200.00K(-60.0%) |
| Sep 1998 | - | $500.00K(+66.7%) |
| Jun 1998 | - | $300.00K(-57.1%) |
| Mar 1998 | - | $700.00K(+250.0%) |
| Dec 1997 | $200.00K(-66.7%) | $200.00K(-66.7%) |
| Sep 1997 | - | $600.00K(-14.3%) |
| Jun 1997 | - | $700.00K(0.0%) |
| Mar 1997 | - | $700.00K(+16.7%) |
| Dec 1996 | $600.00K(+50.0%) | $600.00K(0.0%) |
| Sep 1996 | - | $600.00K(-25.0%) |
| Jun 1996 | - | $800.00K(+100.0%) |
| Mar 1996 | - | $400.00K(0.0%) |
| Dec 1995 | $400.00K(+33.3%) | $400.00K(+33.3%) |
| Sep 1995 | - | $300.00K(-25.0%) |
| Jun 1995 | - | $400.00K(+100.0%) |
| Mar 1995 | - | $200.00K(-33.3%) |
| Dec 1994 | $300.00K | $300.00K(-25.0%) |
| Sep 1994 | - | $400.00K(-42.9%) |
| Jun 1994 | - | $700.00K(0.0%) |
| Mar 1994 | - | $700.00K |
FAQ
- What is BioCryst Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual accounts payable year-on-year change?
- What is BioCryst Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly accounts payable year-on-year change?
What is BioCryst Pharmaceuticals annual accounts payable?
The current annual accounts payable of BCRX is $11.64M
What is the all time high annual accounts payable for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual accounts payable is $27.81M
What is BioCryst Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, BCRX annual accounts payable has changed by -$9.25M (-44.27%)
What is BioCryst Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of BCRX is $10.05M
What is the all time high quarterly accounts payable for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly accounts payable is $27.81M
What is BioCryst Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, BCRX quarterly accounts payable has changed by -$1.86M (-15.63%)